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Abstract  
  
Background: As a medicinal herb, Equisetum ramossisemum has been utilized for centuries as a diuretic and has been 
recommended for different disorders. The aim of this study was to investigate the maternal toxicity of aerial parts of Equisetum 
ramosissimum extract on pregnant Sprague-Dawley rats.    
Methods: Females were mated and the coupling time was recorded at gestation day 0– E0. Four experimental groups I, II, III, and 
IV, received daily gavage doses of 0 mg, 500 mg, 250 mg, and 125 mg/kg, respectively, of Equisetum ramosissimum extract.  
Pregnant rats were observed for mortality and toxicological effects during daily treatment. On day E20, samples of blood were 
withdrawn from the retro-orbital sinus under light ether anaesthesia for haematological and clinical chemistry examinations. 
Results: Data analyses detected significant differences in biochemical and haematological parameters between the control group and 
other groups receiving extract. 
Conclusion: This study constitutes a first approach to defining adverse effects of using Equisetum ramosissimum as a medicinal 
plant during pregnancy. Daily gavage doses of Equisetum ramosissimum extract produced significant differences in biochemical and 
haematological parameters in pregnant Sprague-Dawley rats as compared to the control group.   
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Introduction 
 
There is no visible difference between medicinal plants and those having an adverse effect on animals (Al-Qura'n, 2005). 
A review of the literature shows that most medicinal plants can be toxic when used in small doses over a long period of time (Al-
Qura'n, 2005). It is known that an accumulation of certain active components, even in small doses, can cause metabolic disturbances 
and toxic symptoms in animals (Al-Qura'n, 2005). Toxicological effects of medicinal plants can be assessed using different 
parameters, including clinical chemistry and haematology data (Petterino and Argentino-Storino, 2006). 
Equisetum ramossisemum is one of the medicinal plants, which is collected, packed and marketed (Syouf and Duwayri, 
1996). European workers have known the toxicological effects of different species of Equisetum for a long time (Rapp, 1954). 
Indeed, some countries have recorded Equisetum ramossisemum as a toxic plant, causing dizziness and cardiac disturbances (Al-
Qura'n, 2005; Forero and Nader, 2011).  
  As a medicinal herb, Equisetums has been utilized for centuries as a diuretic and has been recommended for different 
disorders, including haemoptysis, hemorrhoids, varicose ulcers tuberculosis, and edema (Phillipson and Melville, 1960; Boulos et 
al., 2011; Langhammer and Nilsen, 2013). Nowadays, Equisetums plants are sold as weight loss supplement in South America 
(Boulos et al., 2011). However, it has been reported that Equisetums can cause fatalities among livestock (Phillipson and Melville, 
1960). 
Recent studies suggest that a thiaminase may contribute to these fatalities even though toxicity has been attributed to 
alkaloids (Phillipson and Melville, 1960). Thiaminase I and II enzymatic activities have been detected in Equisetum ramossisemum 
(Meyer, 1989). It is thought that the high thiaminase activity may cause neurodevelopmental toxicity through thiamine depletion 
(Meyer, 1989; García et al., 2011; Tokarnia et al., 2002). Research has shown that animals exposed to Equisetums develop a number 
of neurological disorders, including Polioencephalomalacia (Amat 2013; Bebbington and Wright, 2007). Hypovitaminosis in 
livestock has also been associated with ingesting plants such as Equisetums which contain thiaminase (Finnie et al., 2011). In fact, 
thiaminase in Equisetums was shown to be the actual poison when horses rapidly recovered after injection of 50-100mg of thiamin 
per day (Pohl, et al., 1955).  
Many case studies revealed the potential toxicity of Equisetums in humans. For example, the ingestion of a commonly 
used supplement of Equisetums for weight loss caused the death of a healthy female after cardiopulmonary arrest (Boulos et al., 
2011). The patient developed generalized symptoms of thiamine deficiency (Boulos et al., 2011). Another example of the potential 
toxicity of Equisetums in humans is that of a man who developed hepatotoxicity after drinking Equisetums juice for a period of time 
(Klnçalp et al., 2012). Still, other case studies correlate thiamine deficiency with the use of Equisetums supplements and 
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neurodevelopmental disorders (García et al., 2011). For instance, a mother utilized Equisetums supplements a year before giving 
birth to a girl with autism spectrum disorder (García et al., 2011). 
The chemical composition of essential oils from Equisetum ramossisemum (In press) revealed that the oils contain a high 
content of monoterpenoids and sesquiterpenoids as compared to the oils of other Equisetums (Saxena and Basit, 1982). Various 
toxicities have been ascribed to oils that contain terpenes (Gordon et al., 1982). Among these are reports of cytotoxic effects on 
different organs, including liver, lungs, and the central nervous system (Gordon et al., 1982). 
Reports describing toxic effects of Equisetums in animals are prominent in the literature. However, there is very little information 
about the toxicity of Equisetums in humans (Tago et al., 2010). Most doses recorded for Equisetums intake are based on historical 
use or expert belief (Boulos et al., 2011). Thus, given the limited data concerning prescribed safe and effective doses of Equisetums, 
especially during pregnancy, we were motivated to study the toxic effect of aerial parts of Equisetum ramossisemum on female 
Sprague-Dawley rats.  
 
 
Material and Methods 
Plant preparation and extraction  
 
Equisetum ramossisemum was obtained from a local market and authenticated by Dr. Dawud Al-Eisawi, Professor of 
Botany, Biology Department, and The University of Jordan. Aerial parts of Equisetum ramossisemum (500 g) were grounded and 
extracted with a total of 10 L of 95% ethanol at room temperature over 5 days. After that, the solution was filtered and concentrated 
to a semisolid form using a rotary evaporator. 
 
 
Animal grouping, treatment and data collection  
 
Male and female Sprague-Dawley rats were obtained from the animal house of the Faculty of Medicine, Jordan University 
of Science and Tecchnology, Irbid, Jordan. Rats were used after one week of quarantine and accommodation in an animal room with 
constant temperature and humidity, which operated under a12-h light/12-h dark cycle. Rats were fed with a standard rodent diet and 
tap water ad libitum, except for a short fasting period before oral administration of extract doses.  
For mating, an adult virgin female rat, at least 11 weeks old and weighing approximately 187 g, was placed with an adult 
male in the same cage overnight. Observation of vaginal plug was considered as embryonic day 0 (E0). All animal procedures were 
conducted in accordance with Jordanian Regulations for Animal Experimentation and Care and were approved by the Institutional 
Animal Care and Use Committee.  
Mated females were randomly distributed into four groups. Group I received 0mg as control. Groups II, III, and IV 
received doses of 500 mg, 250 mg, and 125 mg/kg, respectively. 
The doses of Equisetum ramossisemum extract were administrated once a day in 2 mL of water solution through gavage. Treatment 
was from E0 to E19 for all groups. Animals were observed daily for mortality and toxicological effects. On day E20, Samples of 
blood for haematological and clinical chemistry examinations were withdrawn under light ether anaesthesia from the retro-orbital 
sinus. 
Blood was aliquoted into two different test tubes to generate blood plasma (tube with anticoagulant) and blood serum (tube 
without anticoagulant). Hematological examinations included the following parameters: Red blood cells count (RBC), hemoglobin 
concentration (Hb), hematocrit (Ht), mean corpuscular value (MCV), mean corpuscular hemoglobin (MCH), mean corpuscular 
hemoglobin concentration (MCHC), platelet count (PLT), red blood cells distribution width (RDW),white blood cells count (WBC), 
neutrophils (NP), lymphocytes (LC), and  monocytes (MC). Serum biochemistry was performed to examine  glucose (Glu), urea(U), 
creatinine (CRN),sodium(Na), potassium (K), calcium (Ca), Chloride(Cl), phosphorus (P), total bilirubin (T-Bil), total protein (TP), 
albumin (ALB), globulins (G), albumin/ globulins ratio (A/G), total cholesterol (T-Cho),triglycerides (TG), alkaline phosphatase 
(ALP) , aspartate aminotransferase (AST), alanine aminotransferase (ALT), and  gamma glutamyl transferase (GGT). Analyses for 
hematology and serum biochemistry were conducted at Shamla Medical Laboratories (Zarka, Jordan) using automatic analyzing 
machines, Erma PCE-210(N) and ACE clinical chemistry system for blood and serum analyses, respectively.  
Resulting data were fed into Statistical Package for the Social Science (SPSS 20) software and analyzed using descriptive 
analysis and One-Way Analysis of Variance (ANOVA). A p value <0.05 was considered statistically significant. 
 
Results 
Serum Biochemistry 
 
To study the effect of Equisetum ramosissimum extract on serum biochemistry among pregnant Sprague-Dawley rats, we 
utilized One-Way ANOVA analyses. Results (Table 1) revealed that there are statistically significant differences in four serum 
factors TP, G, ALB, and GLU detected between Group I and Group II. 
For TP, F (3, 32) = 8.643, p = 0.000, the difference was not only between Groups I (M = 68.11, SD= 4.53) and II (M = 53.57, SD= 
5.69) but also between Groups I and III (M = 58.58, SD= 5.16). This relates to the results for G, F (3, 32) = 8.266, p= 0.000 where 
Group I (M = 32.55, SD= 2.55) differed significantly from each of Group II (M = 25.75, SD= 1.98) and Group III (M= 27.44, SD= 
2.54). 
For ALB, F (3, 32) = 6.379, p = 0.002, the difference was not only between Group I (M= 35.58, SD= 2.45) and Group II 
(M= 25.57, SD= 9.07) but also between Group II and IV (M= 35.54, SD=5.59).  
Finally, ANOVA analyses disclosed a significant difference between Group I (M= 5.12, SD = 1.47) and the other groups, with a 
higher mean value for Group I in GLU, F (3, 32) = 8.854, p = 0.000 values.  
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Blood Hematology 
 
One-Way ANOVA analyses were conducted to determine whether there were hematological differences among four 
groups of pregnant Sprague-Dawley rats receiving daily doses of Equisetum ramosissimum extract. Results (Table 2) indicate that 
there are statistically significant differences in three blood parameters: PLT, WBC, and MC. One-Way ANOVA analyses indicated 
that there is a significant difference in PLT values, F (3, 32) = 11.927, p= 0.000. Post-hoc analysis revealed that the difference was 
between Group I (M= 648.00, SD= 86.18) and Group II (M= 479.11, SD= 143.24) as well as between Group II and the other groups 
(III and IV) with lower mean values for Group II. Similarly, for WBC, F (3, 32) = 3.153, p = 0.038, the difference was between 
Group I (M= 6.51, SD= 1.48) and Group II (M= 4.14, SD= 1.24).  
With respect to MC, F (3, 32) = 33.910, p = 0.000, the difference was between Group I (M=1.22, SD= 0.44) and Group II 
(M= 7.00, SD=   2.23) as well as between Group II and other groups (III and IV) with higher mean values for Group II.  
 
 
Table 1: Serum Biochemistry Results for Pregnant Sprague-Dawley Rats Given Equisetum ramosissimum Extract, (n=9) 
 
Parameters Units GI(0mg/kg) GII(500mg/kg) GIII(250mg/kg) GIV(125mg/kg) 
Glu mmol/l 5.12±1.47 2.83±0.80a 2.55±1.12a 3.26±1.16a 
U mmol/l 8.94±1.61 10.58±2.38 8.54±1.07 8.75±3.20 
CRN µmol/l 85.06±9.14 89.18±22.19 59.91±9.55 79.06±16.09 
G g/l 32.55±2.55 25.75±1.98a 27.44±2.54a 30.03±4.65 
ALB g/l 35.58±2.45 25.57±9.07a 31.14±2.68 35.54±5.59 
A/G ratio 1.08±0.06 1.10±0.05 1.13±0.05 1.17±0.04 
TP g/l 68.11±4.53 53.57±5.69a 58.58±5.16a 65.68±10.20 
TG mmol/l 0.82±0.27 2.23±2.36 2.40±2.65 1.34±0.92 
T-Cho mmol/l 1.5±0.21 1.31±0.19 1.36±0.48 1.24±0.47 
T-Bil µmol/l 5.05±.1.38 9.33±6.86 10.52±5.92 7.50±4.05 
Na mmol/l 136.0±2.34 134.66±3.77 143.88±11.16 138.22±2.48 
K mmol/l 3.90±0.30 3.96±0.38 4.21±0.36 4.81±3.10 
Cl mmol/l 108.55±2.06 108.66±4.06 112.22±8.10 109.22±2.86 
Ca mmol/l 2.45±0.18 2.35±0.17 2.26±0.20 2.41±0.20 
P mg/dl 6.17±0.37 6.84±0.97 6.12±0.88 6.70±2.01 
AST IU/L 99.11±12.89 114.66±17.14 129.77±44.06 74.88±25.54 
ALT IU/L 33.33±7.41 43.22±6.15 31.55±19.22 28.77±12.07 
GGT IU/L 10.33±1.22 14.11±5.01 9.0±5.50 11.0±2.00 
ALP IU/L 173.66±95.61 103.44±33.01 79.66±21.85 132.55±86.87 
Note. Values are mean ± SD.  aSignificantly different from the control group (p<0.05).  
 
 
Table 2: Hematological Data for Pregnant Sprague-Dawley Rats Given Equisetum ramosissimum Extract, (n=9) 
 
Parameters Units GI(0 mg/kg) GII(500 mg/kg) GIII(250 mg/kg) GIV(125 mg/kg) 
RBC x106 /µl 7.12±0.33 6.49±0.79 7.02±0.79 7.31±0.84 
Hb g/dl 14.27±0.65 12.76±2.20 14.24±1.54 14.47±1.39 
Ht % 41.58±1.61 37.12±5.82 41.24±4.85 42.77±4.68 
MCV fl 58.40±1.15 56.97±3.31 58.71±2.48 58.60±2.56 
MCH pg 20.02±0.46 19.56±1.61 20.30±0.66 19.86±0.60 
MCHC g/dl 34.32±0.43 34.31±0.99 34.56±0.86 33.90±1.14 
PLT x103 /µl 648.0±86.18 479.11±143.24a 766.66±79.12 664.66±93.02 
RDW % 15.88±0.63 15.95±0.68 16.22±0.97 16.23±1.14 
WBC x103 /µl 6.51±1.48 4.14±1.24a 4.78±1.70 6.17±2.78 
NP % 28.22±6.74 33.44±5.89 29.55±6.10 35.55±13.62 
LC % 70.44±7.31 59.33±7.64 68.77±6.61 62.66±13.27 
MC % 1.22±0.44 7.00±2.23a 1.77±0.97 1.77±1.30 
Note. Values are mean ± SD. aSignificantly different from the control group (p<0.05).  
 
 
 
 
Discussion 
 
A wide spread belief is that plants are naturally safe, not real drugs, and are beneficial for human health (Colombo et al., 
2009). However, an increasing number of medicinal plant poisonings has been registered since the mid-90s (Colombo et al., 2009). 
We investigated one such plant, Equisetum ramossisemum, because of its wide spread use, especially among pregnant mammals 
(Langhammer and Nilsen, 2013). No studies, to our knowledge, have questioned the effects of Equisetums on a pregnant mammal. 
To this end, we have utilized Equisetum ramossisemum extract to study hematological and serum biochemical changes in pregnant 
Sprague-Dawley rats.  
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Data obtained in this study for the control group are consistent with results from many studies utilizing pregnant rats 
(Honda et al., 2008; De Rijk et al., 2002; Urasoko et al., 2009; LaBorde et al., 1999; Lynch et al., 2011; Syahida et al., 2012; Liberati 
et al., 2004; Ahokas et al., 1984; Han et al., 2010).  
 Results also show a significant reduction of Glu levels in pregnant rats after the oral administration of Equisetum 
ramossisemum extract. Studies utilizing rats and other animal models have reported the same effect of Equisetums extracts on 
glucose levels (Revilla et al., 2002; Cetto et al., 2000; Soleimani et al., 2000). In fact, it was demonstrated that a water extract of the 
aerial parts of Equisetum myriochaetum created a hypoglycemic effect in type 2 diabetic patients (Revilla et al., 2002). In addition, 
plasma glucose levels in diabetic rats were lowered after oral administration of Equisetum myriochaetum extract (Cetto et al., 2000). 
Other Equisetum species have also produced significant antidiabetic activity in rats (Soleimani et al., 2000). 
  No imbalances in serum electrolytes such as Na, Cl, Ca, P, and K were observed (Table 1) although it is known that some 
Equisetums increase diuresis without a change in electrolytes (Combest et al., 2005). Moreover, our data for values of Na, Cl, Ca, P, 
and K in serum are consistent with data resulting from female rats treated with Equisetum arvense (Tago et al., 2010). For Na and K 
values, this finding is consistent with a reported human case study (Klnçalp et al., 2012). 
 The values for   triglycerides, cholesterol, creatinine and urea, show no significant differences (Table 1). This result is also 
consistent with results obtained for a man subjected to 500ml/day of boiled Equisetum arvense juice for two weeks (Klnçalp et al., 
2012). Furthermore, our data for triglycerides, cholesterol, creatinine, urea, A/G, and ALP concentrations show no significant 
differences, a finding consistent with results reported for female rats treated with Equisetum arvense (Tago et al., 2010). 
We found that the levels of ALP in animals treated with the highest dose of extract were lower as compared to the control 
group. These levels of ALP were comparable to those recorded for two studies of Equisetums toxicity in rats ((Tago et al., 2010; 
Baracho et al., 2009). 
Liver test parameters, including AST, GGT, ALT and T-Bil show an obvious tendency to increase in the group treated 
with the highest dose of Equisetum ramossisemum extract, which may indicate that the extract caused some change in the liver 
(Klnçalp., 2012). Hepatic effects produced et al by Equisetum ramossisemum in rats seem to be related to the dosage. Acute 
hepatoxicity was not observed in our study, which utilized doses of Equisetum ramossisemum extract at 500, 250, and 125 mg/kg. 
However, a study has shown that high doses of Equisetum arvense in rats produced significant hepatic damage (Baracho et al., 
2009). In contrast, another study found that regular doses of Equisetum arvense have a hepatoprotective effect in rats (Baracho et al., 
2009). 
A significant decrease was detected in TP, ALB and G (Table 1). These data may indicate hypoproteinemia, which is a 
common finding in liver damage (Larrey, 2001). The significant decrease in values for three haematological factors, PLT, WBC, and 
MC (Table 2) may indicate that Equisetum ramosissimum extract has an effect on the haemopoetic system of the rat, when 
administered orally at the doses used in this study. In a study to evaluate anti-inflammatory effects 
of Equisetum arvense extract in mice, findings demonstrated that the extract has anti-inflammatory property (Do Monte et al., 2004). 
Another study questioning the effect of Equisetums mixture on rheumatoid arthritis patients revealed that the mixture down regulates 
preinflammatory factor, tumor necrosis factor alpha (TNF-α), levels in patient serums (Jiang et al., 2014). An additional study, using 
human peripheral lymphocytes, has shown that treatment with Equisetum arvense reduced production of TNF-α (Gründemann et al., 
2014). 
Given our current results, we hypothesize that the effects of Equisetum ramossisemum extract on pregnant Sprague-
Dawley rats support a role for anti TNF-α. Studies in rats and in humans provide solid documentations that Equisetums extract 
treatments reduce production of the preinflammatory factor TNF-α (Jiang et al., 2014; Gründemann et al., 2014). 
Interestingly, minor elevations of transaminases such as AST and ALT (Table 1) that we observed in rats have also been documented 
in patients recovering from anti-TNF therapies (Coffin et al., 2011). Additionally, leucopenia and thrombocytopenia have been 
reported as side effects in humans receiving TNF_ blocking therapy (Pathare et al., 2006). Leucopenia and thrombocytopenia are 
also documented in this study (Table 2).  
Excitingly, results documented in humans after intravenous anti TNF-α treatment showed that there is an increase in 
plasma triglyceride levels with no difference in total cholesterol levels (Cauza et al., 2006). Still, other studies utilizing rodents also 
reported increased levels in triglycerides after intravenous anti TNF-α treatment (Cauza et al., 2006), similar to elevations in TG 
levels we detected in all rats treated with the extract (Table 1). 
In summary, our hypothesis that Equisetum ramossisemum extract treatments may reduce production of TNF-α will be 
tested in animals to determine if the extract plays a role in regulating TNF-α. 
 
 
Conclusion 
 
Data analyses indicate that daily gavage doses of Equisetum ramosissimum extract produced significant differences in 
biochemical and haematological parameters in pregnant Sprague-Dawley rats as compared to the control group.   
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